Vascular complications in 305 severely ill patients with COVID-19: a cohort study
Authors:
- Rebeca Mangabeira CorreiaRCRebeca Mangabeira Correia
- Brena Costa SantosBSBrena Costa Santos
- Ana Alyra Garcia CarvalhoACAna Alyra Garcia Carvalho
- Libnah Leal AreiasLALibnah Leal Areias
- Danielle Akemi Bergara KuramotoDKDanielle Akemi Bergara Kuramoto
- Mariana Raffo PeredaMPMariana Raffo Pereda
- Ana Laura e Silva AidarAAAna Laura e Silva Aidar
- Caroline Nicacio Bessa ClezarCCCaroline Nicacio Bessa Clezar
- Marcello Erich ReicherMRMarcello Erich Reicher
- Jorge Eduardo de AmorimJAJorge Eduardo de Amorim
- Ronald Luiz Gomes FlumignanRFRonald Luiz Gomes Flumignan
- Luis Carlos Uta NakanoLNLuis Carlos Uta Nakano
Open Access
- 1 January 2023
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 141 (5)
Abstract
Although an association has been made between coronavirus disease 2019 (COVID-19) and microvascular disease, data on vascular complications (other than venous thromboembolism) are sparse. To investigate the vascular complications in severely ill patients hospitalized with COVID-19 and their association with all-cause mortality. This cohort study was conducted at the Universidade Federal de São Paulo, Brazil. All 305 consecutive patients diagnosed with COVID-19 and hospitalized in the intensive care unit (ICU) of a tertiary university hospital from April 2 to July 17, 2021, were included and followed up for 30 days. Of these, 193 (63.3%) were male, and the mean age was 59.9 years (standard deviation = 14.34). The mortality rate was 56.3% (172 patients), and 72 (23.6%) patients developed at least one vascular complication during the follow-up period. Vascular complications were more prevalent in the non-survivors (28.5%) than in the survivors (17.3%) group and included disseminated intravascular coagulation (DIC, 10.8%), deep vein thrombosis (8.2%), acrocyanosis (7.5%), and necrosis of the extremities (2%). DIC (adjusted odds ratio (aOR) 2.30, 95% confidence interval (CI) 1.01–5.24, P = 0.046) and acrocyanosis (aOR 5.21, 95% CI 1.48–18.27, P = 0.009) were significantly more prevalent in the non-survivors than in the survivors group. Vascular complications in critically ill COVID-19 patients are common (23.6%) and can be closely related to the mortality rate (56.3%) until 30 days after ICU admission. Macrovascular complications have direct implications for mortality, which is the main outcome of the management of COVID-19. RBR-4qjzh7 (https://ensaiosclinicos.gov.br/rg/RBR-4qjzh7).Keywords
This publication has 32 references indexed in Scilit:
- Potential Effects of Coronaviruses on the Cardiovascular SystemJAMA Cardiology, 2020
- Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?The Lancet Gastroenterology & Hepatology, 2020
- The Novel Coronavirus Originating in Wuhan, ChinaJAMA, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolismBlood Advances, 2018
- Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus InfectionThe Journal of Immunology, 2017
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.2001
- Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular CoagulationThrombosis and Haemostasis, 2001